SBFM Stock Analysis: Buy, Sell, or Hold?
SBFM - Sunshine Biopharma Inc.
$1.32
0.15 (12.82%)
▲
5d:
-7.69%
30d:
-39.45%
90d:
+20.0%
HOLD
LOW Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 11, 2026
6d
Get Alerted When SBFM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SBFM shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SBFM shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$3.78
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$2.35
43.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBFM is currently trading at $1.32, which is considered oversold relative to its 30-day fair value range of $1.44 to $2.13. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.8) compared to its historical average (13.5). Remarkably, the market is currently pricing in an annual earnings decline of 24.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SBFM is in a uptrend. Immediate support is located at $1.10, while resistance sits at $1.88. The stock is showing strong short-term momentum, up 12.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $56.00 (+4686.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SBFM is in a uptrend. Immediate support is located at $1.10, while resistance sits at $1.88. The stock is showing strong short-term momentum, up 12.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $56.00 (+4686.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.44 -
$2.13
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+12.8%)
- BULLISH: Trading 4686.3% below Wall St target ($56.00)
- CAUTION: Recommendation downgraded due to -7.7% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.44 -
$2.13
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.10
Resistance Level
$1.88
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.85
Wall Street Target
$56.00
(+4686.3%)
Revenue Growth (YoY)
-9.1%
Profit Margin
-17.0%
Valuation Discount vs History
-24.4% cheaper
PE vs Historical
5.9 vs 13.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-24.4%
(market-implied from PE analysis)
1-Year Target
$1.05
(-10%)
2-Year Target
$0.95
(-19%)
3-Year Target
$0.85
(-27%)
3-Yr Target (if PE normalizes)
(PE: 6→14)
$1.97
(+68%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.8 to 13.5
Stabilization Target:
$2.70
(+130.8%)
PE Expansion Potential:
+130.8%
Share & Embed Analysis
Last updated: August 04, 2026 12:32 PM ET
Data refreshes hourly during market hours. Next update: 1:32 PM
Data refreshes hourly during market hours. Next update: 1:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBFM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$211 | 58 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$112 | 49 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 59 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$113 | 46 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$663 | 48 HOLD |
